We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
+7.29%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+631.22%
AUM
$22.1B
AUM Growth
+$302M
(+1.4%)
Cap. Flow
-$1.3B
Cap. Flow
% of AUM
-5.9%
Top 10 Holdings %
Top 10 Hldgs %
11.41%
Holding
3,562
New
1,146
Increased
641
Reduced
606
Closed
971
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Biogen
BIIB
|
+$148M |
| 2 |
Netflix
NFLX
|
+$119M |
| 3 |
Airbnb
ABNB
|
+$111M |
| 4 |
XYZ
Block Inc
XYZ
|
+$89.5M |
| 5 |
Danaher
DHR
|
+$88.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Charles River Laboratories
CRL
|
+$212M |
| 2 |
Alibaba
BABA
|
+$172M |
| 3 |
Zoetis
ZTS
|
+$133M |
| 4 |
TransUnion
TRU
|
+$124M |
| 5 |
Baidu
BIDU
|
+$111M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 20.88% |
| 2 | Financials | 13.4% |
| 3 | Consumer Discretionary | 12.06% |
| 4 | Technology | 11.2% |
| 5 | Communication Services | 8.08% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Dick's Sporting Goods
DKS
$18.4B
| $26.3M | 0.12% |
262,873
+132,501
| +102% | +$11.9M |
|
177
Fair Isaac
FICO
$28.7B
| $26.3M | 0.12% |
+52,244
| New | +$26.4M |
|
178
Elevance Health
ELV
$81.9B
| $25.8M | 0.12% |
67,652
-123,385
| -65% | -$47.2M |
|
179
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
| $25.7M | 0.12% |
228,676
-63,465
| -22% | -$7.06M |
|
180
Public Service Enterprise Group
PEG
$39.8B
| $25.6M | 0.12% |
428,349
+405,659
| +1,788% | +$25.1M |
|
181
NIO
NIO
$11.3B
| $25.6M | 0.12% |
480,623
-184,081
| -28% | -$7.37M |
|
182
Ross Stores
ROST
$76.6B
| $25.5M | 0.12% |
+205,717
| New | +$25.7M |
|
183
Freeport-McMoran
FCX
$90B
| $25.4M | 0.12% |
685,741
-858,158
| -56% | -$33.4M |
|
184
Ardelyx
ARDX
$1.24B
| $25.4M | 0.11% |
3,348,363
+240,628
| +8% | +$1.78M |
|
185
GrowGeneration
GRWG
$82.9M
| $25.4M | 0.11% |
527,400
-96,261
| -15% | -$4.22M |
|
|
TXNM
186
TXNM Energy Inc
TXNM
$6.47B
| $25.2M | 0.11% |
517,225
-44,263
| -8% | -$2.18M |
|
187
Zillow
Z
$7.04B
| $25.2M | 0.11% |
+205,934
| New | +$25.1M |
|
188
iShares TIPS Bond ETF
TIP
$14.5B
| $25.1M | 0.11% |
+196,179
| New | +$24.9M |
|
189
ZIM Integrated Shipping Services
ZIM
$3B
| $24.8M | 0.11% |
552,686
+344,388
| +165% | +$13.3M |
|
|
ESPR
190
DELISTED
Esperion Therapeutics
ESPR
| $24.8M | 0.11% |
1,172,070
+142,369
| +14% | +$3.43M |
|
191
Prudential Financial
PRU
$41.7B
| $24.8M | 0.11% |
241,639
-127,029
| -34% | -$13M |
|
192
NextEra Energy
NEE
$187B
| $24.7M | 0.11% |
337,545
+230,656
| +216% | +$17.3M |
|
193
CALL
iShares MSCI Emerging Markets ETF
EEM
$28B
| $24.6M | 0.11% |
446,000
-99,700
| -18% | -$5.42M |
|
194
Ecolab
ECL
$75.6B
| $24.6M | 0.11% |
+119,378
| New | +$25.9M |
|
195
DTE Energy
DTE
$31.1B
| $24.4M | 0.11% |
221,383
+115,619
| +109% | +$13.5M |
|
|
ATVI
196
DELISTED
Activision Blizzard
ATVI
| $24.4M | 0.11% |
+255,332
| New | +$24.2M |
|
197
Verizon
VZ
$194B
| $24.3M | 0.11% |
433,935
-346,431
| -44% | -$19.9M |
|
|
ALXN
198
DELISTED
Alexion Pharmaceuticals
ALXN
| $24.1M | 0.11% |
131,070
-225,196
| -63% | -$38.7M |
|
|
TWTR
199
CALL
DELISTED
Twitter, Inc.
TWTR
| $23.8M | 0.11% |
345,300
+277,300
| +408% | +$17M |
|
|
SGEN
200
DELISTED
Seagen Inc. Common Stock
SGEN
| $23.5M | 0.11% |
148,635
-143,637
| -49% | -$21.3M |
|
Similar funds
Marshall Wace's Q2 2021 Portfolio in Review
As of Q2 2021, Marshall Wace held 3,562 positions worth $22.1B, up 1.4% from $21.8B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Marshall Wace withdrew a net $1.3B in Q2 2021, closing 971 positions and reducing 606 holdings. Its most notable exit was Pinterest, an estimated $88.8M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 21% of assets, up from 20% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Marshall Wace opened a new position in West Pharmaceutical worth $55.8M.
- Marshall Wace's largest Q2 2021 buy was West Pharmaceutical: 155,316 shares worth $55.8M.
- Marshall Wace added most to Biogen in Q2 2021, an estimated $148M increase.
- Marshall Wace's biggest Q2 2021 reduction was Charles River Laboratories, cutting an estimated $212M.
- Marshall Wace fully exited Pinterest in Q2 2021, selling an estimated $88.8M.
- Marshall Wace's ten largest holdings make up 11% of its $22.1B portfolio in Q2 2021.
- Marshall Wace opened 1,146 new positions and closed 971 in Q2 2021.
- Marshall Wace's portfolio value rose 1.4% quarter-over-quarter to $22.1B.
Based on Marshall Wace's 13F filing for Q2 2021, filed 13 Aug 2021.